Northumbria Pharma’s ambition is to become a leading speciality pharma company. In addition to our strong internal development pipeline, we are actively seeking opportunities to acquire individual products, or portfolios of products and have established a strong contact network within the industry to facilitate this.
In the past year we have completed the acquisition of 28 product licenses.
We are open to considering acquisitions in any therapy area or geographic region, although we are particularly interested in products with sales in the UK and Irish markets
Our evaluation process is handled by a small group of key decision makers, ensuring a rapid and thorough assessment. Regulatory, medical and quality assessments are all handled by our internal team, who will then manage the transition arrangements to ensure a smooth a process as possible for our partners.
If you have an opportunity you would like to discuss please get in touch: email@example.com or call +44 (0) 1740 625 271.